Tag: Medication-related osteonecrosis of the jaw

Tag Visualization: Top 50 related tags by occurrence

Recent Related Articles to Medication-related osteonecrosis of the jaw

FDA Approves First Denosumab Biosimilar

Added to Collection on: 2024-03-05 19:19:19

Tags for this article:

Monoclonal antibodies

Amgen

Denosumab

Pharmaceutical industry

Click the tags to see associated articles and topics

View Article Details

Fracture Risk Lowest for Alendronate, Pamidronate Use During MM Treatment

Added to Collection on: 2024-03-21 22:00:36

Tags for this article:

Osteonecrosis of the jaw

Click the tags to see associated articles and topics

View Article Details

Ultragenyx and Mereo BioPharma Announce New Phase 2 Data from Phase 2/3 Orbit Study ...

Added to Collection on: 2024-06-12 19:07:38

Tags for this article:

Osteogenesis imperfecta

Mereo BioPharma Group plc

Ultragenyx Pharmaceutical Inc

Click the tags to see associated articles and topics

View Article Details

Long-Term Risk of Rib Fractures Following SBRT for Localized NSCLC - Physician's Weekly

Added to Collection on: 2024-08-31 18:54:59

Tags for this article:

Non-small-cell lung cancer

Click the tags to see associated articles and topics

View Article Details

Tau(t)ing glucocorticoid binding | Cell Research - Nature

Added to Collection on: 2025-01-02 01:56:02

Tags for this article:

Click the tags to see associated articles and topics

View Article Details

mAbxience Announces European Commission Approval of Denosumab Biosimilars

Added to Collection on: 2025-07-02 15:12:06

Tags for this article:

Biotechnology products

Contract manufacturing organization

Pharmaceutical industry in India

mAbxience

Click the tags to see associated articles and topics

View Article Details

Orthopaedic Surgery receives over $2.2 million in research funding from defense department

Added to Collection on: 2025-07-15 17:56:11

Tags for this article:

Aging-associated diseases

Post-traumatic arthritis

Gabriela Loots

Click the tags to see associated articles and topics

View Article Details

Saudi Arabia Osteoporosis Drugs Market to Reach US$ 308.84 Million by 2033

Added to Collection on: 2025-08-22 14:56:18

Tags for this article:

Osteopathies

Aging-associated diseases

Click the tags to see associated articles and topics

View Article Details

FDA Approves Biocon Biologics' Denosumab Biosimilars: Bosaya and Aukelso

Added to Collection on: 2025-09-18 15:52:38

Tags for this article:

Monoclonal antibodies

Click the tags to see associated articles and topics

View Article Details

Bone Resorption Market Expected to Grow Significantly by 2032 - The Globe and Mail

Added to Collection on: 2025-10-07 19:33:20

Tags for this article:

Click the tags to see associated articles and topics

View Article Details

Tag: Medication-related osteonecrosis of the jaw

Recent Related Articles to Medication-related osteonecrosis of the jaw

FDA Approves First Denosumab Biosimilar

Fracture Risk Lowest for Alendronate, Pamidronate Use During MM Treatment

Ultragenyx and Mereo BioPharma Announce New Phase 2 Data from Phase 2/3 Orbit Study ...

Long-Term Risk of Rib Fractures Following SBRT for Localized NSCLC - Physician's Weekly

Tau(t)ing glucocorticoid binding | Cell Research - Nature

mAbxience Announces European Commission Approval of Denosumab Biosimilars

Orthopaedic Surgery receives over $2.2 million in research funding from defense department

Saudi Arabia Osteoporosis Drugs Market to Reach US$ 308.84 Million by 2033

FDA Approves Biocon Biologics' Denosumab Biosimilars: Bosaya and Aukelso

Bone Resorption Market Expected to Grow Significantly by 2032 - The Globe and Mail

Create dashboard for Tag: Medication-related osteonecrosis of the jaw